Skip navigation

Overcome Regulatory and Clinical Hurdles to Produce Consistent and Impactful Cannabis-Based Therapies

November 30-December 1, 2017
  • Denver, CO

CBI's Bio/Pharma Forum on Cannabis-Based Science & Medicine is designed to help the medical and advocacy communities come together to design evidencebased communication strategies to arm the industry with the tools it needs to design a streamlined cross-industry approach to therapy development. Dive into scientific development challenges, legal hurdles, improving patient access and outcomes and examine the state of disorders and pathologies with potential cannabis-based treatments.

Cross-Industry Strategies and Collaboration to Improve Research and Access Frameworks:

  • Gain an understanding of current regulatory challenges
    and expected changes
  • Learn lab-side strategies for refinement, measurement
    and development
  • Build consensus and collaborate to build a communication
    strategy for pursuing cannabis-based research
  • Benchmark with leading cannabis-based medication
    designers to decrease time to approval
  • Develop techniques for designing medicinal marijuana
    by pathology
  • Understand patient needs in medicinal marijuana
    capabilities and tolerances
  • Achieve consistency in plant growth, THC count and efficacy

Bio/Pharma Forum on Cannabis-Based Science & Medicine

Overcome Regulatory and Clinical Hurdles to Produce Consistent and Impactful Cannabis-Based Therapies

CBI's Bio/Pharma Forum on Cannabis-Based Science & Medicine is designed to help the medical and advocacy communities come together to design evidencebased communication strategies to arm the industry with the tools it needs to design a streamlined cross-industry approach to therapy development. Dive into scientific development challenges, legal hurdles, improving patient access and outcomes and examine the state of disorders and pathologies with potential cannabis-based treatments.

Cross-Industry Strategies and Collaboration to Improve Research and Access Frameworks:

  • Gain an understanding of current regulatory challenges
    and expected changes
  • Learn lab-side strategies for refinement, measurement
    and development
  • Build consensus and collaborate to build a communication
    strategy for pursuing cannabis-based research
  • Benchmark with leading cannabis-based medication
    designers to decrease time to approval
  • Develop techniques for designing medicinal marijuana
    by pathology
  • Understand patient needs in medicinal marijuana
    capabilities and tolerances
  • Achieve consistency in plant growth, THC count and efficacy